Financial
Recent change of ownership; current owner not yet confirmed from official filings.
Financial health not assessed until ownership and accounts are verified.
Clinisys
HQ United Kingdom · Europe
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
At a glance
Financial health
Band: Not assessed
Customer rating
No reviews yet
Financial health
Band: Not assessed
Recent change of ownership; current owner not yet confirmed from official filings.
Financial health not assessed until ownership and accounts are verified.
Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
Products & services
Products not yet catalogued.
Risk summary
Full risk page with sources →Researched 8 Nov 2026
Adverse media
No adverse media involving Clinisys found in HSH's search of the last 24 months. Jul 2025: Clinisys acquired US lab software company Orchard Software from Francisco Partners; terms were not disclosed.
Cyber & information governance
No data breaches, ransomware incidents or regulator action involving Clinisys found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Regulatory & clinical safety
Apr 2025: Health Canada listed a Type II recall of a Clinisys SQ Blood Bank instrument driver, after partial data from a timed-out sample could merge with the next sample's data; customers were told to contact the manufacturer.
Contract performance
Sep 2025: Aneurin Bevan University Health Board's blood transfusion service went live on Clinisys WinPath, replacing an end-of-life LIMS, with staff reporting a smooth switch. No terminations or disputes involving Clinisys found in HSH's search of the last 24 months.
Competitors
No competitors linked yet.